vs

Side-by-side financial comparison of Innate Pharma SA (IPHA) and TAKEDA PHARMACEUTICAL CO LTD (TAK). Click either name above to swap in a different company.

aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IPHA
IPHA
TAK
TAK
Q2 25
$4.3M
Q1 24
$4.0M
Net Profit
IPHA
IPHA
TAK
TAK
Q2 25
$144.2K
Q1 24
$317.0K
Gross Margin
IPHA
IPHA
TAK
TAK
Q2 25
66.5%
Q1 24
69.1%
Operating Margin
IPHA
IPHA
TAK
TAK
Q2 25
5.0%
Q1 24
12.2%
Net Margin
IPHA
IPHA
TAK
TAK
Q2 25
3.4%
Q1 24
7.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons